Houston, TXNCT05211570Now EnrollingIRB Ready

Acute Myeloid Leukemia Refractory Clinical Trial in Houston, TX

Access cutting-edge acute myeloid leukemia refractory treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by AB Science

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access acute myeloid leukemia refractory specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acute myeloid leukemia refractory treatment provided free

Apply for This Houston Location

Check if you qualify for this acute myeloid leukemia refractory clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Acute Myeloid Leukemia Refractory Study in Houston

The primary objective is to define the safety and tolerability of AB8939 in patients with AML by determining the dose-limiting toxicities, the maximum tolerated dose, and the recommended dose for dose expansion study.

Sponsor: AB Science

Who Can Participate

Inclusion Criteria

Patients with documented diagnosis of acute myeloid leukemia (AML) based on the last version of the World Health Organization classification and eligible to second or third line of treatment.
Patients with documented diagnosis of refractory melyodisplastic syndrome in second or third line of treatment, and with high risk at prognosis based on the IPSS-R scoring system.
ECOG performance status ≤ 1
Patients are able to understand, sign, and date the written informed consent form at screening visit prior to any protocol-specific procedures
Patients are able and willing to comply with study procedures as per protocol, including bone marrow biopsies Key

Exclusion Criteria

Patients eligible to a standard of care
Patients eligible to hematopoietic stem cell transplantation (HSCT) at the time of inclusion
Patients diagnosed with acute promyelocytic leukemia (M3)
Patients with clinically active CNS leukemia
Patients with HSCT within 100 days prior to the first administration of AB8939
Women who are lactating/breastfeeding or who plan to breastfeed while on study
Women with a positive pregnancy test Other protocol-defined inclusion/exclusion criteria may apply EXPANSION COHORT STUDY Key Inclusion Criteria:
Patients with documented diagnosis of acute myeloid leukemia (AML) based on the last version of the World Health Organization classification and eligible to second or third line of treatment.
ECOG performance status ≤ 2
Patients are able to understand, sign, and date the written informed consent form at screening visit prior to any protocol-specific procedures
Patients are able and willing to comply with study procedures as per protocol, including bone marrow biopsies Key Exclusion Criteria:
Patients eligible to a standard of care
Patients eligible to hematopoietic stem cell transplantation (HSCT) at the time of inclusion
Patients diagnosed with acute promyelocytic leukemia (M3)
Patients with clinically active CNS leukemia
Patients with HSCT within 100 days prior to the first administration of AB8939
Women who are lactating/breastfeeding or who plan to breastfeed while on study
Women with a positive pregnancy test Other protocol-defined inclusion/exclusion criteria may apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT05211570) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acute Myeloid Leukemia Refractory Treatment Options in Houston, TX

If you're searching for acute myeloid leukemia refractory treatment options in Houston, TX, this clinical trial (NCT05211570) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute myeloid leukemia refractory specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acute myeloid leukemia refractory clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Houston, TX

See all leukemia clinical trials recruiting in Houston — not just this study.

Browse Leukemia Trials in Houston →

Browse More Trials by Condition

Leukemia TrialsAcute Myeloid Leukemia TrialsHeart Attack TrialsRheumatoid Arthritis TrialsMyocardial Infarction TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX